Sexual dysfunction in women with hyperprolactinemia: a pilot study report - PubMed
Comparative Study
Sexual dysfunction in women with hyperprolactinemia: a pilot study report
Pinar Kadioglu et al. J Urol. 2005 Nov.
Abstract
Purpose: Hyperprolactinemia is a common hormonal disorder in women that may affect the phases of female sexual function (FSD). We investigated sexual function in patients with hyperprolactinemia.
Material and methods: A total of 25 women with primary hyperprolactinemia and 16 age matched voluntary healthy women who served as the as control group were evaluated with a detailed medical and sexual history, including a female sexual function index (FSFI) questionnaire and the Beck Depression Inventory. Serum prolactin, dehydroepiandrosterone sulfate, free testosterone, androstenedione, 17alpha-hydroxyprogesterone, estradiol, free thyroxin and thyrotropin were measured. These variables were compared statistically between the 2 groups.
Results: Except for prolactin serum hormone levels in women with hyperprolactinemia were not different from those in the control group. The median total FSFI score was 23.40 (IQR 17.70 to 27.30) in the hyperprolactinemic group, whereas healthy women had a median total FSFI score of 31.10 (IQR 27.55 to 32.88, p < 0.0001). FSD was diagnosed in 22 of 25 patients (88%), while 4 of 16 healthy women (25%) had FSD (p = 0.03). Desire (p = 0.001), arousal (p < 0.0001), lubrication (p = 0.001), orgasm (p = 0.001), satisfaction (p = 0.07) and pain (p = 0.003) domain scores were also significantly lower in women with hyperprolactinemia. Total FSFI (p = 0.009, r = -0.405), desire (p = 0.001, r = -0.512), arousal (p = 0.002, r = -0.466), orgasm (p = 0.026, r = 0.348) and satisfaction (p = 0.041, r = -0.320) scores negatively correlated with mean prolactin but not with the other hormones measured.
Conclusions: A significant percent of women with hyperprolactinemia whom we evaluated had sexual dysfunction. No hormonal changes other than prolactin and no depression was found as a cause of FSD.
Comment in
-
Re: sexual dysfunction in women with hyperprolactinemia: a pilot study report.
Delgrange E. Delgrange E. J Urol. 2006 Aug;176(2):841-2; author reply 842. doi: 10.1016/j.juro.2006.03.051. J Urol. 2006. PMID: 16813963 No abstract available.
Similar articles
-
Sexual dysfunction in obese and overweight women.
Yaylali GF, Tekekoglu S, Akin F. Yaylali GF, et al. Int J Impot Res. 2010 Jul-Aug;22(4):220-6. doi: 10.1038/ijir.2010.7. Epub 2010 May 20. Int J Impot Res. 2010. PMID: 20485360
-
Verit FF, Verit A, Yeni E. Verit FF, et al. Arch Gynecol Obstet. 2006 Aug;274(5):297-302. doi: 10.1007/s00404-006-0178-3. Epub 2006 May 17. Arch Gynecol Obstet. 2006. PMID: 16705463
-
Women with low libido: correlation of decreased androgen levels with female sexual function index.
Turna B, Apaydin E, Semerci B, Altay B, Cikili N, Nazli O. Turna B, et al. Int J Impot Res. 2005 Mar-Apr;17(2):148-53. doi: 10.1038/sj.ijir.3901294. Int J Impot Res. 2005. PMID: 15592425
-
Parish SJ. Parish SJ. J Fam Pract. 2009 Jul;58(7 Suppl Hypoactive):S16-21. J Fam Pract. 2009. PMID: 19825314 Review.
-
Elzevier HW, Nieuwkamer BB, Pelger RC, Lycklama à Nijeholt AA. Elzevier HW, et al. J Sex Med. 2007 Mar;4(2):406-16. doi: 10.1111/j.1743-6109.2006.00257.x. J Sex Med. 2007. PMID: 17367436 Review.
Cited by
-
Growth hormone, prolactin, and sexuality.
Galdiero M, Pivonello R, Grasso LF, Cozzolino A, Colao A. Galdiero M, et al. J Endocrinol Invest. 2012 Sep;35(8):782-94. doi: 10.1007/BF03345805. J Endocrinol Invest. 2012. PMID: 23014134 Review.
-
Zeinalzadeh S, Mohagheghzadeh AA, Ahmadinezhad F, Akbarzadeh M. Zeinalzadeh S, et al. J Family Med Prim Care. 2019 Nov 15;8(11):3614-3620. doi: 10.4103/jfmpc.jfmpc_525_19. eCollection 2019 Nov. J Family Med Prim Care. 2019. PMID: 31803662 Free PMC article.
-
Maseroli E, Verde N, Cipriani S, Rastrelli G, Alfaroli C, Ravelli SA, Costeniero D, Scairati R, Minnetti M, Petraglia F, Auriemma RS, Nappi RE, Maggi M, Vignozzi L. Maseroli E, et al. J Endocrinol Invest. 2023 Dec;46(12):2481-2492. doi: 10.1007/s40618-023-02101-8. Epub 2023 May 18. J Endocrinol Invest. 2023. PMID: 37204690 Free PMC article.
-
Changes of androgens levels in menopausal women.
Brzozowska M, Lewiński A. Brzozowska M, et al. Prz Menopauzalny. 2020 Dec;19(4):151-154. doi: 10.5114/pm.2020.101941. Epub 2021 Jan 7. Prz Menopauzalny. 2020. PMID: 33488324 Free PMC article.
-
Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women.
Canat M, Canat L, Öztürk FY, Eroğlu H, Atalay HA, Altuntaş Y. Canat M, et al. Int Urol Nephrol. 2016 Nov;48(11):1789-1795. doi: 10.1007/s11255-016-1396-7. Epub 2016 Aug 13. Int Urol Nephrol. 2016. PMID: 27522658
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical